News & Updates

From patent to clinical tests, the goals of Human Motor Patterns.

European patent 13/08/2025

The European Patent granted: HMP signs an epochal milestone for the sector!

It's official: the European Patent has been granted. A historic moment for HMP, which marks the full recognition of the uniqueness, originality and technological value of our invention at an international level.

This achievement is the result of a long journey made up of study, multidisciplinary work, targeted investments and great determination. The patent is not just a legal protection, but a certification of quality and innovation, which now opens new opportunities for development, growth and competitive positioning in global markets.

The enthusiasm is sky high and we want to extend a sincere thank you to all those who made this success possible: the partners who supported us with confidence, the strategic partners who believed in our vision, and all the collaborators who put professionalism and passion into every phase of the project.

HMP celebrates this milestone with pride, aware that the road is still long, but the foundations are now stronger than ever.

Prototype 12/04/2025

Our first prototype is reality: all tests completed successfully!

After a year of intense and satisfying work, we have officially completed the tests on our proof of concept: the first prototype of the medical device is ready and fully functional. This is a concrete and symbolic step at the same time, which marks the beginning of the most operational phase of our technological vision.

The result was possible thanks to the synergy of the HMP healthcare team, the collaboration with Ortopedia Mancini, and the work between the inventor Dr. Pino Strano and our team of software developers. The date of April 12, 2025 represented a historic moment: the prototype was shown in action with enthusiasm from the members present.

University Partnerships 03/24/2025

Strategic alliances: partnership signed with the Universities of Tor Vergata and Link Campus!

HMP enters into two very high-profile academic partnerships, fundamental to accelerating the development of the project and consolidating its scientific, technological and market bases.

With Tor Vergata the collaboration involves the Engineering Department for the development of the definitive prototype and the implementation of AI. Link Campus will conduct tests on athletes from its sports teams and support financial and marketing strategies for market entry.

Events 06/14/2024

HMP protagonist at WMF 2024: our first public presentation on the "We Make Future" stage

On 14 June 2024 HMP was selected at the prestigious international event "We Make Future" in Bologna, "Future of Health" category. On stage our CEO, Dr. Giovanni Maresca spoke about the vision and innovative value of our technology.

On this occasion it was announced that the first version of the Proof of Concept Prototype will be ready by October 2024. Our system, based on Precision Medicine, will soon be tested to demonstrate its effectiveness in the diagnosis and management of musculoskeletal disorders.

Intellectual property 03/25/2024

Our technology looks to the world: the international extension of the patent has started

HMP has started the international patent extension process, filing the PCT application with WIPO in 9 strategically selected countries to use intellectual property as a competitive lever.

This strategy allows HMP to consolidate its competitive advantage, increase its asset value, access the Patent Box regime and offer investors a concrete guarantee of reliability and potential.

Press 03/14/2024

HMP awarded among the best 300 Italian startups by the Italy USA Foundation

Our startup received the Innovation Award from the Italy USA Foundation, assigned to the 300 most promising entrepreneurial companies on the Italian scene, with objective criteria based on the Business Register.

The ceremony was held in the Chamber of Deputies. The founders Giovanni Maresca and Francesca Romana Latini accepted the award: a strong signal that confirms HMP's commitment to carrying forward a unique medical technology in the field of musculoskeletal disorders.

Funding 06/03/2024

The second fundraising was successfully closed: new capital to accelerate the project

The second round of investments concluded successfully, confirming the confidence and growing interest around the HMP project. The €50,000 necessary for the international extension of the patent has been reached.

This result allows us to strengthen the foundations of the project and look with confidence to the next phases, which include strengthening the team, technological development and consolidating our positioning in the healthcare market. A heartfelt thank you goes to all the investors who have chosen to believe in our vision.

Assessment 31/10/2023

The assessment study concluded: the innovation underlying our system validated

HMP has made use of the collaboration with Quantum Leap S.r.l. for an in-depth analysis of hundreds of international patent families. The study confirmed that HMP positions itself as a in a completely new market segment.

Quantum Leap has estimated the intellectual property — still in the pending phase — with a value of more than half a million euros. At the same time, Expert Lab S.r.l. conducted a technical-operational feasibility study confirming the concrete feasibility of the project.

Intellectual property 09/30/2022

The "Confirmation" of the European Patent presented: another step towards official recognition

The application for "Confirmation" of the European patent has been formally filed, marking a further crucial step in the path of protecting our innovation.

The texts of the patent documentation were drafted by the inventor Dr. Giovanni Maresca, in collaboration with Studio Torta S.p.A. of Turin, specialized in intellectual property at an international level. This synergy has given rise to solid documentation strategically designed to fully exploit the technological content of the invention.

Funding 07/13/2022

HMP convinces investors: the first round closed with results above expectations

The initial round of investments concluded successfully, leading to the raising of approximately €135,000 in just 30 days, thanks to the entry of new capital partners who strongly believed in the vision proposed by HMP.

At the same time, key professional figures — including a psychologist, an engineer and a software developer — have chosen to contribute voluntarily, without financial compensation. The funds will be allocated to market research, IP assessment and filing of the "Confirmation" of the European pre-patent.

Patent 01/10/2021

Positive opinion from the International Authority: our BMPOD passes the first big test

The international authority expressed a favorable opinion on the BMPOD solution, confirming the innovative potential of the patent initially filed in 2021 by the physiatrist Dr. Giovanni Maresca, now CEO of HMP.

Following this approval, HMP officially acquired all rights to the patent in June 2022. The patent claims submitted were fully approved, including those relating to the use of artificial intelligence and the use of a cyber loop — the technological cornerstones of the proposed innovation.